tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:8F8 Stock Latest News

SynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
Company AnnouncementsSynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
12h ago
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
PremiumCompany Announcements
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
1d ago
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
PremiumCompany Announcements
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
9d ago
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
PremiumCompany Announcements
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
12d ago
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
PremiumCompany Announcements
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
19d ago
SynAct Pharma Names Long-Serving Finance Executive as Interim CFO
PremiumCompany AnnouncementsSynAct Pharma Names Long-Serving Finance Executive as Interim CFO
1M ago
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
Premium
Company Announcements
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
1M ago
SynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
Premium
Company Announcements
SynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
2M ago
SynAct Pharma Leadership Buys Shares as Key Rheumatoid Arthritis Milestone Nears
PremiumCompany Announcements
SynAct Pharma Leadership Buys Shares as Key Rheumatoid Arthritis Milestone Nears
2M ago
SynAct Pharma AB Appoints Nomination Committee for 2026 AGM
PremiumCompany Announcements
SynAct Pharma AB Appoints Nomination Committee for 2026 AGM
2M ago
SynAct Pharma to Attend J.P. Morgan Healthcare Conference for Strategic Engagements
PremiumCompany Announcements
SynAct Pharma to Attend J.P. Morgan Healthcare Conference for Strategic Engagements
2M ago
SynAct Pharma AB Implements New Share Option Program and Share Management Strategy
PremiumCompany Announcements
SynAct Pharma AB Implements New Share Option Program and Share Management Strategy
3M ago
SynAct Pharma to Present at Redeye Autoimmune and Inflammatory Diseases Event
PremiumCompany AnnouncementsSynAct Pharma to Present at Redeye Autoimmune and Inflammatory Diseases Event
3M ago
SynAct Pharma Advances Resomelagon Phase 2b Study for Rheumatoid Arthritis
Premium
Company Announcements
SynAct Pharma Advances Resomelagon Phase 2b Study for Rheumatoid Arthritis
4M ago
SynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
Premium
Company Announcements
SynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
4M ago
SynAct Pharma’s Q3 2025 Interim Report Highlights
PremiumCompany Announcements
SynAct Pharma’s Q3 2025 Interim Report Highlights
4M ago
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
PremiumCompany Announcements
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
4M ago
Edison Investment Research Initiates Coverage of SynAct Pharma
PremiumCompany Announcements
Edison Investment Research Initiates Coverage of SynAct Pharma
4M ago
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Rheumatoid Arthritis Treatment?
PremiumCompany Announcements
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Rheumatoid Arthritis Treatment?
4M ago
8F8
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Nephrology
PremiumCompany AnnouncementsSynAct Pharma’s AP1189 Study: A Potential Game-Changer in Nephrology
4M ago
8F8
SynAct Pharma Proposes Share Buy-Back to Boost Capital Structure
Premium
Company Announcements
SynAct Pharma Proposes Share Buy-Back to Boost Capital Structure
5M ago
SynAct Pharma to Engage at Nordic Life Science Days 2025
Premium
Company Announcements
SynAct Pharma to Engage at Nordic Life Science Days 2025
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >